Efficacy of Natalizumab Proven Even with Extended Dose Interval
There is news about Natalizumab (Tysabri®), which was expected, but it is still good that clarity now exists: In August 2021, the first results of the NOVA study were communicated, which compared the effectiveness of
Continue reading






